Join the IMPRESIVE network
Three clear pathways — whether you hold data, design studies, or make decisions.
Data partners
Suitable for national claims databases, hospital EHR databases, disease registries, biobank-linked databases and research data centers.
IMPRESIVE provides a clear pathway: data inventory → CDM transformation → quality control → participation in the distributed data network. Raw data never leave your institution; you run the shared programs locally and return aggregate results.
Participation criteria
- A clear data-governance mechanism
- Ability to run local analysis
- Ability to follow a common protocol
- Willingness to share aggregated results
- A local PI or data custodian
- Willingness to take part in standardization, integration and visualization
Researchers
Suitable for pharmacoepidemiologists, clinician-scientists, statisticians, data scientists, visualization experts, graduate students and postdoctoral researchers.
Ways to take part
- Study proposal
- Protocol writing
- Phenotype development
- Analysis module development
- Dashboard design
- Result interpretation
- Manuscript writing
Industry / regulatory / policy
Suitable for pharmaceutical companies, regulatory agencies, HTA bodies, public-health agencies and international research networks.
Directions for collaboration
- Disease burden evaluation
- Drug safety evaluation
- Comparative effectiveness research
- Post-marketing surveillance
- Treatment pattern assessment
- Transportability assessment
- Methodological consultation
- Decision-grade RWE framework
Submit a research topic
Proposal submission
Tell us about a disease or treatment question that may benefit from cross-national real-world evidence. We will follow up to assess feasibility.
Research topics are assessed and prioritized through AsPEN or an appropriate expert governance mechanism; IMPRESIVE provides the infrastructure on which approved studies are executed.